Latest Endocan Corporation (ENDO) Headlines E
Post# of 22
Posted On: 03/09/2014 6:06:01 PM
Latest Endocan Corporation (ENDO) Headlines
Endocan (ENDO) Delighted with Landmark Congressional Action on Hemp Cultivation and Research; Following House Action, the Senate and President Obama Expected to Make Law of the Land
PR Newswire - Tue Feb 04, 7:04AM CST
Endocan Corporation (OTC: ENDO), a U.S. Company specializing in cannabis, hemp, and cannabinoid formulation-based health and wellness solutions, is pleased that the U.S. Congress and President Obama appear on the verge of approving the first key law to legalize hemp cultivation and advanced research on a federal level, creating substantial economic opportunities going forward.
Endocan Provides Shareholder Guidance for its Medicine Dispensing Systems (MDS) Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Management
PR Newswire - Mon Feb 03, 7:45AM CST
Endocan Corporation (NASDAQ OTC: ENDO), a U.S. Company specializing in cannabis and cannabinoid formulation-based health and wellness solutions, provides shareholder guidance concerning its consultant MDS, a subsidiary of Medbox, Inc., and the multi-million dollar agreement for multi-state product release licensing, medical cannabis dispensary management, and cultivation.
Endocan (ENDO) Delighted with Landmark Congressional Action on Hemp Cultivation and Research; Following House Action, the Senate and President Obama Expected to Make Law of the Land
PR Newswire - Tue Feb 04, 7:04AM CST
Endocan Corporation (OTC: ENDO), a U.S. Company specializing in cannabis, hemp, and cannabinoid formulation-based health and wellness solutions, is pleased that the U.S. Congress and President Obama appear on the verge of approving the first key law to legalize hemp cultivation and advanced research on a federal level, creating substantial economic opportunities going forward.
Endocan Provides Shareholder Guidance for its Medicine Dispensing Systems (MDS) Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Management
PR Newswire - Mon Feb 03, 7:45AM CST
Endocan Corporation (NASDAQ OTC: ENDO), a U.S. Company specializing in cannabis and cannabinoid formulation-based health and wellness solutions, provides shareholder guidance concerning its consultant MDS, a subsidiary of Medbox, Inc., and the multi-million dollar agreement for multi-state product release licensing, medical cannabis dispensary management, and cultivation.
(0)
(0)